The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRIT Capital Partners Regulatory News (RCP)

Share Price Information for RIT Capital Partners (RCP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,828.00
Bid: 1,828.00
Ask: 1,834.00
Change: -12.00 (-0.65%)
Spread: 6.00 (0.328%)
Open: 1,844.00
High: 1,844.00
Low: 1,824.00
Prev. Close: 1,840.00
RCP Live PriceLast checked at -
RIT Capital Partners is an Investment Trust

To invest in a widely diversified, international portfolio across a range of asset classes, both quoted and unquoted; to allocate part of the portfolio to exceptional managers in order to ensure access to the best external talent available.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Net Asset Value(s)

7 Feb 2023 07:00

RNS Number : 0825P
RIT Capital Partners PLC
07 February 2023
 

RIT CAPITAL PARTNERS PLC (LEI: P31Q1NLTW35JJGHA4667)

7 February 2023

 

 

December 2022 Preliminary Unaudited Net Asset Value

 

The preliminary, unaudited, diluted net asset value of RIT Capital Partners plc (the Company) as at 31 December 2022 (with debt at fair value) was 2,388p per £1 ordinary share (30 November 2022: 2,454p).

This represented a decline of -2.7% for the month of December, outperforming the MSCI ACWI (50% £) which fell -5.0% in the month. The outperformance was driven by our quoted equity book, and positive contributions from both our absolute return & credit book as well as real assets. The NAV reflected the six-monthly revaluation of our direct private investments to 31 December 2022, and, as normal, the 30 September valuations from external managers for ~94% of our private funds (with around 6% at 31 December).

 

2022 Preliminary Unaudited Performance

 

Last year was one of the most challenging years for financial markets for more than a decade, with a multitude of issues causing almost all asset classes to decline during the year. The S&P 500, the NASDAQ and the FTSE 250 closed down -18%, -32% and -17% respectively. Government bonds provided no safe harbour, with long-term US and UK bonds losing -29% and -40% respectively. Our NAV was not immune from these pressures, with a preliminary, unaudited NAV per share total return (including dividends) of -13.3% compared to the ACWI of -12.9%. With inflation at multi-year highs, our inflation measure of CPI+3.0%, was 13.5% for the year. 

Key factors impacting our return for the year were:

-

Retaining one of our lowest quoted equity exposures in a decade, coupled with action we took within the quoted equity portfolio, helped limit the downside. Nevertheless, this book saw a negative contribution of around -6.7%;

-

Private investments detracted by -6.2% of NAV, split broadly equally across the directs and funds, giving back a portion of the ~+34% NAV contribution across 2020 and 2021;

-

Our absolute return and credit book held up reasonably well, albeit with some mixed performance from our macro managers;

-

Through our currency positioning, we ensured that much of our exposure was held outside the weakening sterling, resulting in a positive contribution for the year.

While any short-term decline in NAV is uncomfortable, our aims and objectives are long term. Over the last three years our NAV returned a preliminary ~25% against the ACWI at 17.7%. Similarly, our 5-year performance of around 41% compares favourably to the ACWI at 35.5%, and over 10-years our NAV (including dividends) has grown by approximately 140%.

As normal at this stage of our year end, the preliminary NAV is an estimate and remains subject to adjustment and audit. Full details will be included in the 2022 Annual Report & Accounts, which is expected to be published at the end of February.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVVQLFBXLLBBBQ
Date   Source Headline
8th Dec 20227:00 amRNSTransaction in Own Shares
2nd Dec 20227:00 amRNSTransaction in Own Shares
1st Dec 20227:00 amRNSTransaction in Own Shares
15th Nov 20227:00 amRNSNet Asset Value(s)
14th Oct 20227:00 amRNSNet Asset Value(s)
3rd Oct 20227:00 amRNSTransaction in Own Shares
30th Sep 20227:00 amRNSTransaction in Own Shares
29th Sep 20227:00 amRNSTransaction in Own Shares
27th Sep 20227:00 amRNSTransaction in Own Shares
26th Sep 20227:00 amRNSTransaction in Own Shares
20th Sep 20227:00 amRNSTransaction in Own Shares
16th Sep 20227:00 amRNSTransaction in Own Shares
14th Sep 20227:00 amRNSNet Asset Value(s)
7th Sep 20227:00 amRNSTransaction in Own Shares
6th Sep 20227:00 amRNSTransaction in Own Shares
17th Aug 20225:29 pmRNSDirector/PDMR Shareholding
12th Aug 20227:00 amRNSNet Asset Value(s)
11th Aug 20229:45 amRNSBoard Appointments
2nd Aug 20227:00 amRNSHalf-year Report
20th Jul 20227:00 amRNSNet Asset Value(s)
21st Jun 20227:00 amRNSTransaction in Own Shares
20th Jun 20227:00 amRNSTransaction in Own Shares
16th Jun 20227:00 amRNSNet Asset Value(s)
17th May 20227:00 amRNSNet Asset Value(s)
4th May 20224:51 pmRNSResult of AGM
27th Apr 20222:24 pmRNSDirector/PDMR Shareholding
26th Apr 20224:40 pmRNSBoard Appointment
19th Apr 20227:00 amRNSNet Asset Value(s)
14th Mar 20227:00 amRNSNet Asset Value(s)
1st Mar 20227:00 amRNSAnnual Financial Report
23rd Feb 20224:18 pmRNSHolding(s) in Company
22nd Feb 20222:45 pmRNSHolding(s) in Company
17th Feb 20227:00 amRNSNet Asset Value(s)
15th Feb 20224:26 pmRNSHolding(s) in Company
28th Jan 20227:00 amRNSNet Asset Value(s)
15th Dec 20217:00 amRNSNet Asset Value(s)
3rd Dec 20217:00 amRNSDirector Declaration
23rd Nov 20215:22 pmRNSDirector/PDMR Shareholding
15th Nov 20217:00 amRNSNet Asset Value(s)
4th Nov 20214:57 pmRNSBoard Announcements
15th Oct 20217:00 amRNSNet Asset Value(s)
15th Sep 20217:00 amRNSNet Asset Value(s)
16th Aug 20217:00 amRNSNet Asset Value(s)
2nd Aug 20217:00 amRNSHalf-year Report
20th Jul 20217:00 amRNSNet Asset Value(s)
28th Jun 20216:17 pmRNSDirector/PDMR Shareholding
28th Jun 20217:00 amRNSTransaction in Own Shares
22nd Jun 20217:00 amRNSTransaction in Own Shares
15th Jun 20217:00 amRNSNet Asset Value(s)
21st May 20215:15 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.